Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma Meeting Abstract


Authors: Slotkin, E.; Patwardhan, P.; Deraje, S. V. ; Schwartz, G.; Tap, W.
Abstract Title: Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma
Meeting Title: 105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 74
Issue: 19 Suppl.
Meeting Dates: 2014 Apr 5-9
Meeting Location: San Diego, CA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2014-10-01
Language: English
ACCESSION: WOS:000349910205234
DOI: 10.1158/1538-7445.am2014-lb-200
PROVIDER: wos
Notes: Meeting Abstract: LB-200 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Douglas Tap
    372 Tap
  2. Emily Kanaya Slotkin
    65 Slotkin